Key result
A nurse-led home-based biofeedback-assisted breathing relaxation intervention significantly reduced mean systolic blood pressure to 136.93 mmHg compared to 141.06 mmHg with standard care in patients with primary hypertension.
Why the study?
Nurse-led complementary interventions are emerging in chronic illness management, but their role in addressing the autonomic dysregulation underlying hypertension required evaluation.
Does a nurse-led home-based biofeedback-assisted breathing relaxation intervention reduce blood pressure in outpatients with stage I uncomplicated primary hypertension?
RCT (n=346)
Single-blind
Random allocation sequence
No
Does a nurse-led home-based biofeedback-assisted breathing relaxation intervention reduce blood pressure in outpatients with stage I uncomplicated primary hypertension?
A nurse-led home-based biofeedback-assisted breathing relaxation intervention significantly reduces systolic and diastolic blood pressure in patients with stage I primary hypertension.
Answers are grounded in this paper and cite their sources.
Supports nurse-led home biofeedback breathing as adjunct for stage I hypertension; extends RCT evidence for nonpharmacologic primary-care interventions.
Aim: To investigate the effect of nurse-led home-based biofeedback intervention on the blood pressure levels among patients with hypertension. Background: Nurse-led interventions are emerging as cost-effective as well as clinically proven in chronic illness management. Hypertension, a leading long-term cardiovascular condition, has autonomic dysregulation and increased sympathetic tone as its pathophysiological background. Complementary interventions evidenced to interplay hypertension pathophysiology. Design: A pretest–posttest design. Materials and Methods: Uncomplicated primary hypertension outpatients were randomly assigned as study group ( n = 173) and control group ( n = 173) at a tertiary care hospital. Sociodemographic, clinical, and outcome variables [the baseline blood pressure and galvanic skin response (GSR)] were collected. Study group patients were given four teaching sessions of abdominal breathing-assisted relaxation facilitated by GSR biofeedback. Daily home practice was encouraged and monitored to measure the effects on blood pressure and GSR at the end of the 1 st , 2 nd , and 3 rd month of intervention. Results: The study group participants showed significant decrease in mean (SD) systolic [140.77 (8.31) to 136.93 (7.96), F = 469.08] and diastolic blood pressure [88.24 (5.42) to 85.77 (4.66), F = 208.21]. In contrast, control group participants had a mild increase in the mean systolic ( F = 6.02) and diastolic blood pressure ( F = 4.70) values from pretest to posttests. GSR showed a significant increase from 559.63 (226.33) to 615.03 (232.24), ( F = 80.21) from pretest to posttest III. Conclusions: Use of home-based biofeedback-centered behavioral interventions enabled BP reduction among hypertensive patients. Further studies should use biochemical markers of sympathetic nervous system activity to endorse this home-based chronic illness intervention.
No takes yet. Share an insight, caveat, or question.
Elavally et al. (2020) conducted an RCT in Primary hypertension (n=346). Nurse-led home-based biofeedback-assisted breathing relaxation intervention vs. Standard care was evaluated on Mean systolic blood pressure at 12 weeks (p=<0.001). A nurse-led home-based biofeedback-assisted breathing relaxation intervention significantly reduced mean systolic blood pressure to 136.93 mmHg compared to 141.06 mmHg with standard care in patients with primary hypertension.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: